Ginkgo Biloba 60 mg

Ginkgo Biloba 60 mg

NOW4.8 (3,877 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 120 servings
Goals

Product analysis

62 out of 100

Ginkgo Biloba 60 mg keeps the formula focused on ginkgo, with the main compound groups and their proportions disclosed. That detail helps comparison with other ginkgo preparations.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The main ginkgo compound groups are named. Their relative preparation quality remains uncertain.

Ingredient Transparency100

Ingredient amounts, sources and applicable component proportions are clear. That makes serving comparisons easier.

Value For Money40

Value for the ginkgo contribution remains uncertain. Conflicting quantity declarations also limit a dependable serving comparison.

Customer Satisfaction89

Customer ratings are strongly favorable. A large rating pool provides a broader view of customer satisfaction.

Product Focus57

A single botanical keeps the formula focused. Its expected contribution across the intended uses remains limited rather than broadly established.

Format
Capsule
Container
120 Capsule(s)
Per serving
$0.09
Customer rating
4.8 · 3,877 ratings
Report analysis

Goals

Cognitive Support
Impact
Moderate effect
A Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic

Ginkgo provides targeted support for the circulation-related side of cognitive function. The saved serving assessment treats the declared material as an unidentified preparation, so its evidence is less specific than that for a matched trial extract.

How this product is rated for Cognitive Support

Ingredient fit94

The relevant ingredients give the formula a clear connection to cognitive support. The assessed ingredient amounts fully meet the saved amount comparison.
Goal fit
The relevant ingredients give the formula a clear connection to cognitive support.
Dose adequacy
The assessed ingredient amounts fully meet the saved amount comparison.

Pathways40

The clearest contribution involves cerebral blood flow, with meaningful coverage in the saved findings. One assessed mechanism reaches meaningful coverage, so support remains focused.
Depth
The clearest contribution involves cerebral blood flow, with meaningful coverage in the saved findings.
Breadth
One assessed mechanism reaches meaningful coverage, so support remains focused.

Evidence25

Ginkgo provides the strongest relevant evidence at an assessed amount, although the support is limited to the outcomes and preparations described. The assessed preparations are not matched to the materials used in the supplied trials.
Evidence strength
Ginkgo provides the strongest relevant evidence at an assessed amount, although the support is limited to the outcomes and preparations described.
Studied preparation
The assessed preparations are not matched to the materials used in the supplied trials.

Formulation logic100

The relevant ingredients can contribute independently or have their needed partner present. No configured ingredient conflict was identified in the saved assessment. All ingredients counted in this finding reach a meaningful amount in the saved comparison.
Partner coverage
The relevant ingredients can contribute independently or have their needed partner present.
Conflicts
No configured ingredient conflict was identified in the saved assessment.
Effective doses
All ingredients counted in this finding reach a meaningful amount in the saved comparison.
Study evidence
Ginkgo Supportive 87 studies
Brain Health
Impact
Moderate effect
A Ingredient FitD- PathwaysC- EvidenceA+ Formulation Logic

Ginkgo provides a limited, situation-dependent contribution in the supplied brain-health assessment, centered on energy processes. The declared total includes different ginkgo materials, so a larger total should not be read as greater cognitive benefit.

How this product is rated for Brain Health

Ingredient fit94

The relevant ingredients fit the goal, with the declared amounts and broader formula focus shaping their contribution.
Goal fit
The relevant ingredients give the formula a clear connection to brain health.
Dose adequacy
The assessed ingredient amount reaches the supplied comparison range.

Pathways43

The main assessed contribution is concentrated in brain energy processes.
Depth
The strongest saved finding concerns brain energy processes, with meaningful but limited coverage.
Breadth
The saved findings concentrate on brain energy processes, rather than several well-covered processes.

Evidence58

Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution. The saved assessment recognizes the preparation for the ingredients included in this finding.
Evidence strength
Ginkgo evidence is mixed and supports only a limited, situation-dependent contribution.
Studied preparation
The saved assessment recognizes the preparation for the ingredients included in this finding.

Formulation logic100

The assessed ingredients need no additional partner, and no configured conflicts were found.
Partner coverage
The assessed ingredients can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied assessment.
Effective doses
The ingredients included in this saved finding meet its amount threshold.
Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
Moderate effect
A Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic

Ginkgo has inconsistent findings for attention, concentration and memory. The supplied 260 mg total does not establish a dependable everyday productivity benefit, and a larger amount should not be read as greater effectiveness.

How this product is rated for Productivity Boost

Ingredient fit94

The saved findings identify 1 relevant ingredients alongside no other active ingredients. The saved amount assessment is strong; undisclosed individual amounts reduce certainty about the contribution.
Goal fit
The saved findings identify 1 relevant ingredients alongside no other active ingredients.
Dose adequacy
The saved amount assessment is strong; undisclosed individual amounts reduce certainty about the contribution.

Pathways13

The strongest assessed area is synaptic plasticity and neuroprotection, with limited coverage. 0 of 3 assessed target areas reach the saved coverage threshold.
Depth
The strongest assessed area is synaptic plasticity and neuroprotection, with limited coverage.
Breadth
0 of 3 assessed target areas reach the saved coverage threshold.

Evidence53

Ginkgo is the strongest evidence contributor at an eligible amount in the saved findings; that comparison does not establish improved work output. The eligible ingredients match the preparations accepted in the saved assessment.
Evidence strength
Ginkgo is the strongest evidence contributor at an eligible amount in the saved findings; that comparison does not establish improved work output.
Studied preparation
The eligible ingredients match the preparations accepted in the saved assessment.

Formulation logic100

The assessed ingredients can contribute alone or have their required partners. No configured ingredient conflicts were identified in the supplied facts. 1 of 1 assessed ingredients meet the saved minimum amount threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partners.
Conflicts
No configured ingredient conflicts were identified in the supplied facts.
Effective doses
1 of 1 assessed ingredients meet the saved minimum amount threshold.
Study evidence
Ginkgo Supportive 20 studies
Mental Focus
Impact
Moderate effect
A Ingredient FitD- PathwaysC EvidenceA+ Formulation Logic

The saved declaration totals 260 mg of ginkgo. Ginkgo has a possible attention-related role, but findings are mixed and declared mass alone does not establish equivalence to a particular extract or a stronger immediate effect.

How this product is rated for Mental Focus

Ingredient fit94

The relevant ingredients keep a clear focus-related emphasis, while the product also has uses beyond attention. The saved findings place the relevant declared amounts at their reference levels.
Goal fit
The relevant ingredients keep a clear focus-related emphasis, while the product also has uses beyond attention.
Dose adequacy
The saved findings place the relevant declared amounts at their reference levels.

Pathways44

The strongest saved connection is cerebral energy supply, with partial coverage. The saved findings identify 1 sufficiently covered focus mechanism, so support remains concentrated rather than broad.
Depth
The strongest saved connection is cerebral energy supply, with partial coverage.
Breadth
The saved findings identify 1 sufficiently covered focus mechanism, so support remains concentrated rather than broad.

Evidence62

Ginkgo provides the strongest saved evidence among ingredients meeting the amount threshold. Ingredient-specific limitations still matter for everyday focus. The saved preparation check is satisfied for the relevant ingredients at qualifying amounts. That finding does not remove limitations in the attention evidence.
Evidence strength
Ginkgo provides the strongest saved evidence among ingredients meeting the amount threshold. Ingredient-specific limitations still matter for everyday focus.
Studied preparation
The saved preparation check is satisfied for the relevant ingredients at qualifying amounts. That finding does not remove limitations in the attention evidence.

Formulation logic100

The saved findings identify no missing required ingredient partner. No configured ingredient conflict was found in the supplied record.
Partner coverage
The saved findings identify no missing required ingredient partner.
Conflicts
No configured ingredient conflict was found in the supplied record.
Effective doses
All ingredients counted in the saved amount check reach its minimum threshold; that threshold is not a guarantee of noticeable benefit.
Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per servingScore
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
60 mg 55
Ginkgo powder
200 mg 55
Gluten Free Men 18–50 Vegan Kosher Women Vegetarian
Report overview
F Composition And Label DisclosureA+ Composition And Label Disclosure
Each serving lists 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder. The extract is described as 6% terpenes with a 50:1 extract ratio; comparable marker details are not recorded for the powder.
How this ingredient is rated

Composition and Label Disclosure10

The extract has a stated 6% terpene content and 50:1 ratio; comparable marker details are not recorded for the powder.
Marker and Preparation Disclosure
The ginkgo extract is listed as 6% terpenes and 50:1; no flavone percentage is recorded for it, or marker percentages for the powder.
Declared Ginkgolic Acid Limit
No qualifying ginkgolic acid limit is recorded for either source; their actual levels are unknown.

Composition and Label Disclosure100

The two amounts are separately disclosed: 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder per serving.
Individual Preparation Amount Disclosure
The two amounts are separately disclosed: 60 mg of ginkgo leaf extract and 200 mg of ginkgo powder per serving.

Commercial Price and Usability

The whole-product serving costs about $0.10. Price is not evaluated for this ingredient.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  3. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  4. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  5. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  6. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  7. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support forGinkgo
  8. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  9. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  10. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  11. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  12. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  13. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  14. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  15. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  16. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  17. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo